Preview

Current Pediatrics

Advanced search

RESTORATION OF MICROBIOCENOSIS OF THE INTESTINES WITHIN THE COMPLEX THERAPY FOR ATOPIC DERMATITIS IN CHILDREN

Abstract

Atopic dermatitis is a wide spread disease in the practices of the pediatrician. Quite often, the development of atopic dermatitis among children is accompanied by dysbacteriosis of the intestines, whose correction assisted by the probiotics is not always efficient. The purpose of the present research was to study the «Primadophilus for children» dietary supplement efficacy and safety to restore microbiocenosis of the intestines among children with atopic dermatitis. 102 patients aged between 6 months and 6 years took a part in the open research. It was discovered that most children, who received the dietary supplement along with the basic therapy, showed restoration of the normal intestinal microflora. The positive dynamics of the skin process evaluated according to SCORAD scale was marked among 76% of children from the main group and among 68% of children from the screening group. The most drastic reduction of the SCORAD index (by 16–20 points) was noted among 52% of children from the main group and only among 30% of children from the screening group (p < 0,05). No side effects were reported during the treatment. Thus, the researchers proved that «Primadophilus for children» was an efficient and safe means for the complex therapy for atopic dermatitis among children.
Key words: microbiocenosis of the intestines, probiotics, atopic dermatitis, children.

About the Authors

I.Yu. Mel'nikova
Saint Petersburg Medical Academy of the Postgraduate Education
Russian Federation


M.M. Goryunova
Saint Petersburg Medical Academy of the Postgraduate Education
Russian Federation




M.V. Samsonova
Saint Petersburg Medical Academy of the Postgraduate Education
Russian Federation


References

1. Isolauri E., Grоnlund M.M., Salminen S. et al. Why don't we bud? J. Pediatr. Gastroenterol. Nutr. 2000; 30 (4): 214–216.

2. Sudo N., Sawamura S., Tanaka K. The requirement of intestinal bacteria flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunology. 1997; 159 (6): 1739–1745.

3. Isolauri E. Probiotics in the prevention and treatment of allergic disease. Pediatric Allergology and Immunology. 2001; 12 (4): 56–59.

4. Kalliomaki M., Salminen A., Arvilommi H. et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001; 357 (9262): 1076–1079.

5. Isolauri E., Rautava S., Kalliomaki M. еt al. Role of probiotics in food hypersensitivity. Current Opinion in Allergy and Clinical Immunology. 2002; 2: 236–271.

6. Matricardi P.M., Bjorksten B., Bonini S. et al. For the EAACI Task Force 7. Microbial products in allergy prevention and therapy. Allergy. 2003; 58: 461–471.

7. Rautava S., Kalliomaki M., Isolauri E. Probiotics during pregnancy and breastfeeding might confer immunomodulatory protection against atopic diseases in the infant. J. Allergy. 2002; 109: 119–121.

8. Isolauri E., Rautava S., Kalliomaki M. et al. Role of probiotics in food hypersensitivity. Curr. Opin. Allergy Clin. Immunol. 2002; 2 (3): 263–271.

9. Kelly D., Conway S., Aminov R. Commensal gut bacteria: mechanisms of immune modulation. J. Immunology. 2005; 26 (6): 326–323.

10. . Шендеров Б.А. Медицинская микробная экология и функциональное питание. Пробиотики и функциональное питание. М.: Грантъ. 2001. Т. 3. С. 288.

11. Veckman V., Miettinen M., Pirhonen J. et al. Streptococcus pyogenes and Lactobacillus rhamnosus differentially induce maturation and production of Th1 type cytokines and chemokines in human monocyte-derived dendritic cells. J. Leukoc. Biol. 2004; 75 (5): 764–771.


Review

For citations:


Mel'nikova I., Goryunova M., Samsonova M. RESTORATION OF MICROBIOCENOSIS OF THE INTESTINES WITHIN THE COMPLEX THERAPY FOR ATOPIC DERMATITIS IN CHILDREN. Current Pediatrics. 2007;6(4):123-127.

Views: 590


ISSN 1682-5527 (Print)
ISSN 1682-5535 (Online)